{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:36Z","timestamp":1791337956797,"version":"4.3.1"},"reference-count":34,"publisher":"The Endocrine Society","issue":"7","funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Height outcome in patients with classic congenital adrenal hyperplasia (CAH) is suboptimal due to glucocorticoid and androgen excess.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In an open, randomized, controlled trial, children with classic CAH were randomized to receive a combination regimen of antiandrogen, aromatase inhibitor, reduced hydrocortisone, and fludrocortisone prior to puberty or standard therapy (hydrocortisone, fludrocortisone). Females continued on antiandrogen during puberty. The primary endpoint was adult height.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 62 children randomized, 45 completed the study. Adult height SDS did not differ between the investigational and control groups (\u22120.34 [0.93] vs \u22120.60 [0.89], respectively), mean difference 0.26 [95% CI \u22120.29, 0.82], P = .35), irrespective of midparental height, but was greater than the predicted adult height pretreatment in both groups (P &amp;lt; .001). Growth rate and rate of bone maturation were reduced in the investigational group prior to puberty, despite lower hydrocortisone dose (7.6 [1.5] vs 15.0 [3.6] mg\/m2\/day, P &amp;lt; .001), and improvement in predicted adult height appeared greater at pubertal onset (P = .049) compared to standard therapy. Antiandrogen treatment during puberty in girls allowed for lower-dose glucocorticoid, and improved height outcome (adult minus midparental height: \u22120.7 [4.6] vs \u22125.6 [5.2] cm, mean difference 4.9 [95% CI 0.09, 9.7], P = .046). Those who received GnRHa had lower growth rate (P = .023) and longer years of unchanged bone age (P = .017), regardless of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prepubertal antiandrogen, aromatase inhibitor combination with reduced hydrocortisone improves short-term predicted height for children with CAH but does not result in taller adult stature than those treated with standard therapy, and is not recommended. Females may benefit from antiandrogen treatment during puberty.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae824","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T15:27:10Z","timestamp":1732894030000},"page":"e2171-e2182","source":"Crossref","is-referenced-by-count":12,"title":["Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-0460","authenticated-orcid":false,"given":"Deborah P","family":"Merke","sequence":"first","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-4559","authenticated-orcid":false,"given":"Ashwini","family":"Mallappa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Sukin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-2218","authenticated-orcid":false,"given":"Margaret F","family":"Keil","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Van Ryzin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvimol Chirathivat","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-5728","authenticated-orcid":false,"suffix":"Jr.","given":"Gordon B","family":"Cutler","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4045-1386","authenticated-orcid":false,"given":"Ninet","family":"Sinaii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"10108","key":"2025082004064486500_dgae824-B1","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"issue":"13","key":"2025082004064486500_dgae824-B2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"2025082004064486500_dgae824-B3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"9","key":"2025082004064486500_dgae824-B4","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1210\/jc.2009-2616","article-title":"Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis","volume":"95","author":"Muthusamy","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"2025082004064486500_dgae824-B5","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM199012273232605","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"323","author":"Cutler","year":"1990","journal-title":"N Engl J Med"},{"issue":"3","key":"2025082004064486500_dgae824-B6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem.85.3.6462","article-title":"Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia","volume":"85","author":"Merke","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082004064486500_dgae824-B7","volume-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959","edition":"2nd ed"},{"issue":"6","key":"2025082004064486500_dgae824-B8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0022-3476(05)80128-3","article-title":"Cortisol production rate in childhood and adolescence","volume":"117","author":"Linder","year":"1990","journal-title":"J Pediatr"},{"issue":"1","key":"2025082004064486500_dgae824-B9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082004064486500_dgae824-B10","author":"Centers for Disease Control and Prevention (CDC)"},{"issue":"12","key":"2025082004064486500_dgae824-B11","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025082004064486500_dgae824-B12","first-page":"e5247","article-title":"Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia","volume":"106","author":"Torky","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025082004064486500_dgae824-B13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/03014467600001791","article-title":"Individual growth in stature: a comparison of four growth studies in the U.S.A","volume":"3","author":"Thissen","year":"1976","journal-title":"Ann Hum Biol"},{"issue":"Suppl 3","key":"2025082004064486500_dgae824-B14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1542\/peds.102.S3.507","article-title":"Growth and normal puberty","volume":"102","author":"Abbassi","year":"1998","journal-title":"Pediatrics"},{"issue":"12","key":"2025082004064486500_dgae824-B15","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1210\/jc.2003-030123","article-title":"CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency","volume":"88","author":"Balsamo","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025082004064486500_dgae824-B16","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1210\/jc.2009-0942","article-title":"Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation","volume":"94","author":"Bonfig","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025082004064486500_dgae824-B17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","article-title":"Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"169","author":"Charmandari","year":"2001","journal-title":"J Endocrinol"},{"key":"2025082004064486500_dgae824-B18","first-page":"113","article-title":"Genetic regulation of the growth plate","volume":"2","author":"Karimian","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2025082004064486500_dgae824-B19","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025082004064486500_dgae824-B20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mpd.2001.110527","article-title":"Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis","volume":"138","author":"Eugster","year":"2001","journal-title":"J Pediatr"},{"issue":"1","key":"2025082004064486500_dgae824-B21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025082004064486500_dgae824-B22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"2025082004064486500_dgae824-B23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198902233200805","article-title":"Treatment of familial male precocious puberty with spironolactone and testolactone","volume":"320","author":"Laue","year":"1989","journal-title":"N Engl J Med"},{"key":"2025082004064486500_dgae824-B24","first-page":"187","volume-title":"Pediatric Adrenal Diseases. Endocrine Development: Workshop, Turin, May 2010","author":"Lui","year":"2010"},{"key":"2025082004064486500_dgae824-B25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2017.07.047","article-title":"Effect of antiandrogen, aromatase inhibitor, and gonadotropin-releasing hormone analog on adult height in familial male precocious puberty","volume":"190","author":"Leschek","year":"2017","journal-title":"J Pediatr"},{"issue":"6","key":"2025082004064486500_dgae824-B26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2404655","article-title":"Phase 3 trial of crinecerfont in pediatric congenital adrenal hyperplasia","volume":"391","author":"Sarafoglou","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"2025082004064486500_dgae824-B27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2404656","article-title":"Phase 3 trial of crinecerfont in adult congenital adrenal hyperplasia","volume":"391","author":"Auchus","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"2025082004064486500_dgae824-B28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41574-022-00655-w","article-title":"Management challenges and therapeutic advances in congenital adrenal hyperplasia","volume":"18","author":"Mallappa","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2025082004064486500_dgae824-B29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency","volume":"337","author":"Carani","year":"1997","journal-title":"N Engl J Med"},{"key":"2025082004064486500_dgae824-B30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000439338","article-title":"Aromatase inhibitors in the treatment of short stature","volume":"30","author":"Hero","year":"2016","journal-title":"Endocr Dev"},{"issue":"6","key":"2025082004064486500_dgae824-B31","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1210\/jc.2018-00208","article-title":"Longitudinal assessment of illnesses, stress dosing, and illness sequelae in patients with congenital adrenal hyperplasia","volume":"103","author":"El-Maouche","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025082004064486500_dgae824-B32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000365570","article-title":"Increased prevalence of testicular adrenal rest tumours during adolescence in congenital adrenal hyperplasia","volume":"82","author":"Claahsen-van der Grinten","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"2025082004064486500_dgae824-B33","doi-asserted-by":"crossref","first-page":"e2063","DOI":"10.1210\/clinem\/dgab051","article-title":"Modified-release hydrocortisone in congenital adrenal hyperplasia","volume":"106","author":"Merke","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025082004064486500_dgae824-B34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrendo.2011.161","article-title":"Aromatase inhibitors in pediatrics","volume":"8","author":"Wit","year":"2012","journal-title":"Nat Rev Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae824\/61156485\/dgae824.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/7\/e2171\/61156485\/dgae824.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/7\/e2171\/61156485\/dgae824.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:06:55Z","timestamp":1755677215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/7\/e2171\/7915466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,12,3]]},"published-print":{"date-parts":[[2025,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae824","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2024,12,3]]}}}